Could the AstraZeneca vaccine cause Guillain-Barré syndrome? We don't know yet — but there's minimal cause for concern

By Nathan Bartlett, Associate Professor, School of Biomedical Sciences and Pharmacy, University of Newcastle

The Therapeutic Goods Administration (TGA) yesterday revealed there have been six reports of Guillain-Barré syndrome in Australia following the AstraZeneca COVID vaccine.

This is an autoimmune disorder, which causes muscle weakness, numbness and tingling. It can be life threatening if it involves the respiratory muscles.

But at this stage, there isn’t cause for serious concern.…

Read complete article

~	In Knife, his memoir of surviving attack, Salman Rushdie confronts a world where liberal principles like free speech are old-fashioned

~	It never rains but it pours: intense rain and flash floods have increased inland in eastern Australia

~	‘It could be the death of the museum’: why research cuts at a South Australian institution have scientists up in arms

~	Rugby stadiums are sold as an economic asset – but NZ needs to ask if they’re really worth it

~	The ‘devil comet’ 12P/Pons-Brooks has finally become visible from Australia. What can we expect?

~	Some families push back against journalists who mine social media for photos – they have every right to

~	I wholeheartedly recommend The President: a brilliant revival of a play of decay, terror and revulsion

~	Many prisoners go years without touching a smartphone. It means they struggle to navigate life on the outside

~	Good news: midlife health is about more than a waist measurement. Here’s why

~	Are 2 mid-career AFL retirements a sign Australian athletes are taking brain health more seriously?